|
 |
|
Autotransfusion
New intraoperative autologous technologies (autotransfusion) from Advanced
Medical Resources eliminate the barriers of blood banking with multiple
benefits to both the patient and health-care systems. In addition, the
most-advanced equipment, which AMR will provide, simplifies the operator's
ability, which means less decision making during operation. Also available are
services that separate blood components, such as platelets and plasma, prior to
surgery for use, if necessary, during the operation. Separated platelets may be
used to make "platelet gel" which acts both as a sealant and an adhesive to
reduce bleeding.
-
Blood shed during surgery is recovered, cleansed and held for subsequent use,
thereby minimizing use of banked blood and reducing concern about transmission
of bloodborne diseases.
-
The system is completely sealed, reducing exposure of clinicians and
technicians to bloodborne pathogens during cell salvage.
-
Patients can be autotransfused even if they don't meet the blood banking
qualifications for autologous donations due to size or the presence of markers.
-
Oxygen-carrying capacity is superior to that of banked blood.
A major cost benefit; remaining at a constant flat fee, while autologous blood
is $300-$500 per unit.
-
May allay concerns of religious groups opposed to transfusions.
Advanced Medical Resources will place the latest state of-the-art blood
processing system, required disposable items, and if preferred, personnel in
your hospital. With AMR's pay as you go program, blood salvage becomes very
cost-effective. AMR has systems that can keep up with the most rapid blood loss
or a simple single-button system for daily routine cases. Additionally, AMR
will customize and maintain a Quality Assurance program for all your procedures
at your hospital. Maintenance of systems will be the responsibility of AMR. AMR
offers a full complement of programs, dedicated to reliable, dependable
services in your area.
Intra and Postoperative Cell Salvage in Elective Surgery
Intraoperative blood salvage has a high efficacy for saving blood; efficacy is
not that clear for postoperative blood salvage. In both cases, the autologous
blood salvaged should not be used without cell washing. After cell washing,
blood products and the red blood cells (RBC) are of excellent quality. With
various autotransfusion devices, elimination of contaminating substances
resulting in activation processes and cell lysis is achieved in the order of
95%. Function and viability of the red cells are unimpaired, in contrast to
stored blood. A fresh, unstored, unrefrigerated, washed, autologous RBC
concentrate is the best available RBC preparation. This quality can be
guaranteed only if a quality management system is also applied to this field of
transfusion medicine. Product quality can be controlled by hematocrit and
volume and process quality by measurement of protein or albumin concentrations
and microscopic inspection, to evaluate periodic samples for cell recovery,
elimination of contaminants and cell integrity. Microbiological testing can
apparently be omitted, since the few air- and skin-born bacteria involved with
retransfusion of unstored blood have little clinical relevance. Intraoperative
blood salvage can also be performed in cancer surgery after blood irradiation.
Irradiation with 50Gy, in contrast to white blood cell filters, guarantees
efficient elimination of contaminating tumor cells. With this combination of
two established methods, RBC quality is unimpaired. Thus, cancer patients, who
represent a growing demand for transfusions, can be treated without further
impairment of their immune system, and blood resources are saved. Retransfusion
of blood from an area with bacterial contamination is strictly contraindicated.
|
|
|
|
|
|
